Global epidemiology of Trichomonas vaginalis

Sexually Transmitted Infections

Volumn 89, Issue 6, 2013, Pages 418-422

  Poole, Danielle N ^a   McClelland, R Scott ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; ESTROGEN; IRON;

ANTIBIOTIC SENSITIVITY; CHLAMYDIASIS; EPIDEMIOLOGY; FEMALE GENITAL SYSTEM; GENOTYPE; HUMAN; INCIDENCE; MICROSCOPY; MOLECULAR EPIDEMIOLOGY; NEISSERIA GONORRHOEAE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; URINALYSIS; VAGINAL SECRETION;

EPIDEMIOLOGY (GENERAL); SEXUAL HEALTH; TRICHOMONAS;

AGE FACTORS; FEMALE; HUMANS; INCIDENCE; MALE; PREVALENCE; SEXUALLY TRANSMITTED DISEASES; TRICHOMONAS INFECTIONS; TRICHOMONAS VAGINALIS; WORLD HEALTH;

EID: 84884534812     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2013-051075     Document Type: Review

References (30)

1. World Health Organization. Prevalence and incidence of selected sexually transmitted infections, Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis, and Trichomonas vaginalis: methods and results used by the WHO to generate 2005 estimates. Geneva, Switzerland: World Health Organization, 2011.
2. Allsworth JE, Ratner JA, Peipert JF. Trichomoniasis and other sexually transmitted infections: results from the 2001-2004 National Health and Nutrition Examination Surveys. Sex Transm Dis 2009;36:738-44.
3. Sutton M, Sternberg M, Koumans EH, et al. The prevalence of Trichomonas vaginalis infection among reproductive-Age women in the United States, 2001- 2004. Clin Infect Dis 2007;45:1319-26. (Pubitemid 351411908)
4. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993;7:95-102. (Pubitemid 23069039)
5. McClelland RS, Sangare L, Hassan WM, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 2007;195:698-702.
6. Van Der Pol B, Kwok C, Pierre-Louis B, et al. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis 2008;197:548-54. (Pubitemid 351321532)
7. Van Der Pol B, Kraft CS, Williams JA. Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens. J Clin Microbiol 2006;44:366-73. (Pubitemid 43222224)
8. Martin DH, Eschenbach DA, Cotch MF, et al. Double-blind placebo-controlled treatment trial of chlamydia trachomatis endocervical infections in pregnant women. Infect Dis Obstet Gynecol 1997;5:10-17. (Pubitemid 27479403)
9. Horvathova L, Safarikova L, Basler M, et al. Transcriptomic identification of iron-regulated and iron-independent gene copies within the heavily duplicated Trichomonas vaginalis genome. Genome Biol Evol 2012;4:905-17.
10. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. 2001.
11. Carlton JM, Hirt RP, Silva JC, et al. Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis. Science 2007;315:207-12. (Pubitemid 46166360)
12. Snipes LJ, Gamard PM, Narcisi EM, et al. Molecular epidemiology of metronidazole resistance in a population of Trichomonas vaginalis clinical isolates. J Clin Microbiol 2000;38:3004-9. (Pubitemid 30640589)
13. Goodman RP, Ghabrial SA, Fichorova RN, et al. Trichomonasvirus: a new genus of protozoan viruses in the family Totiviridae. Arch Virol 2011;156:171-9.
14. Conrad MD, Gorman AW, Schillinger JA, et al. Extensive genetic diversity, unique population structure and evidence of genetic exchange in the sexually transmitted parasite Trichomonas vaginalis. PLoS Negl Trop Dis 2012;6:e1573.
15. Riley DE, Roberts MC, Takayama T, et al. Development of a polymerase chain reaction-based diagnosis of Trichomonas vaginalis. J ClinMicrobiol 1992;30:465-72.
16. Huppert JS, Batteiger BE, Braslins P, et al. Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens. J Clin Microbiol 2005;43:684-7. (Pubitemid 40256019)
17. Kaydos-Daniels SC, Miller WC, Hoffman I, et al. Validation of a urine-based PCR-enzyme-linked immunosorbent assay for use in clinical research settings to detect Trichomonas vaginalis in men. J Clin Microbiol 2003;41:318-23. (Pubitemid 36098594)
18. Schwebke JR, Hook EW III. High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management. J Infect Dis 2003;188:465-8. (Pubitemid 36960659)
19. Sena AC, Miller WC, Hobbs MM, et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis 2007;44:13-22. (Pubitemid 44968978)
20. Huppert TJ, Hoge RD, Diamond SG, et al. A temporal comparison of BOLD, ASL, and NIRS hemodynamic responses to motor stimuli in adult humans. Neuroimage 2006;29:368-82. (Pubitemid 43065485)
21. Gepshtein R, Leiderman P, Genosar L, et al. Testing the three step excited state proton transfer model by the effect of an excess proton. J Phys Chem A 2005;109:9674-84. (Pubitemid 41598550)
22. Bowden FJ, Garnett GP. Trichomonas vaginalis epidemiology: parameterising and analysing a model of treatment interventions. Sex Transm Infect 2000;76:248-56.
23. Sena AC, Lensing S, Rompalo A, et al. Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: predictors and persistence after therapy. J Infect Dis 2012;206:357-65.
24. Hobbs MM, Swygard H, Schwebke J. Trichomonas vaginalis and Trichomoniasis. In: Holmes KK, Stamm WE, Piot P (eds). Sexually transmitted diseases. McGraw-Hill, 2008:771-93.
25. Figueroa-Angulo EE, Rendon-Gandarilla FJ, Puente-Rivera J, et al. The effects of environmental factors on the virulence of Trichomonas vaginalis. Microbes Infect 2012;14:1411-27.
26. Ruckert C, Stuepp Cdos S, Gottardi B, et al. Steroid hormones alter AMP hydrolysis in intact trophozoites of Trichomonas vaginalis. Parasitol Res 2009;105:1701-6.
27. Baeten JM, Nyange PM, Richardson BA, et al. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol 2001;185:380-5. (Pubitemid 32769440)
28. Sharma R, Pickering J, McCormack WM. Trichomoniasis in a postmenopausal woman cured after discontinuation of estrogen replacement therapy. Sex Transm Dis 1997;24:543-5. (Pubitemid 27459150)
29. Ginocchio CC, Chapin K, Smith JS, et al. Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay. J Clin Microbiol 2012;50:2601-8.
30. Cotch MF, Pastorek JG II, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 1997;24:353-60. (Pubitemid 27306585)